Evidence map›Paper›PMID 3119987›Full record

ArticleMolecular and cellular biology1987

Nature and specificity of lymphokine independence induced by a selectable retroviral vector expressing v-src.

R W Overell, J D Watson, B Gallis, K E Weisser, D Cosman, M B Widmer

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Interleukin 3 binds to a 140-kDa phosphotyrosine-containing cell surface protein.Proceedings of the National Academy of Sciences of the United States of America · 1988
    Article
  9. Dysregulation of growth factor-receptor system in cellular transformation.Japanese journal of cancer research : Gann · 1988
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

R W OverellDepartment of Molecular Biology, Immunex Corporation, Seattle, Washington 98101.
J D Watson
B Gallis
K E Weisser
D Cosman
M B Widmer
IDEX Corporation (United States) · USResearch & Development Corporation · CAUniversity of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A murine retroviral vector, LSNLsrc, has been constructed and examined for its ability to induce growth factor independence in cells normally dependent on interleukin 2 (IL-2) or interleukin 3 (IL-3) for growth. The LSNLsrc vector coexpressed the v-src gene of Rous sarcoma virus and the neo gene from transposon Tn5, allowing infected cells to be selected on the basis of G418 resistance. The murine cell lines CTLL-2 and FD.C/1, which are dependent for growth on IL-2 and IL-3, respectively, were both readily infected with the LSNLsrc virus. LSNLsrc-infected, G418-resistant cultures of FD.C/1 cells were able to give rise to IL-3-independent progeny, but all G418-resistant CTLL-2 cells retained normal IL-2 dependence. The induction of IL-3 independence by v-src was not a direct event, since limiting dilution analysis of the LSNLsrc-infected FD.C/1 cells showed that most of them were IL-3 dependent, despite expression of v-src mRNA and active pp60v-src kinase. However, clones selected from this population in the presence of IL-3 were able to undergo a subsequent progression event and generate IL-3-independent progeny. The generation of factor-independent variants in the clonal cultures was a rare event, as witnessed by the death of most of the cells in each clone when IL-3 was withdrawn. Together, these data indicate that a secondary event, in addition to v-src expression, was required to generate IL-3-independent growth. No evidence was found for an autocrine mechanism of transformation involving IL-2, IL-3, interleukin 4, or granulocyte-macrophage colony-stimulating factor.

Indexed as

OncogenesCell DivisionCell LineGenetic VectorsGrowth SubstancesInterleukin-2Interleukin-3Interleukin-4InterleukinsLymphocyte ActivationOncogene Protein pp60(v-src)Protein-Tyrosine KinasesRetroviridaeRetroviridae ProteinsT-Lymphocytes, CytotoxicGrowth SubstancesInterleukin-2Interleukin-3Interleukin-4InterleukinsOncogene Protein pp60(v-src)Protein-Tyrosine KinasesRetroviridae Proteins

Identifiers

PMID3119987
PMCPMC367989
OpenAlexW2121843801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.